CN114645034B - Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof - Google Patents
Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof Download PDFInfo
- Publication number
- CN114645034B CN114645034B CN202011504714.8A CN202011504714A CN114645034B CN 114645034 B CN114645034 B CN 114645034B CN 202011504714 A CN202011504714 A CN 202011504714A CN 114645034 B CN114645034 B CN 114645034B
- Authority
- CN
- China
- Prior art keywords
- mrl
- lipase
- diglyceride
- enzyme
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 26
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 26
- 230000002194 synthesizing effect Effects 0.000 title claims abstract description 18
- 238000002360 preparation method Methods 0.000 title abstract description 11
- 102000004882 Lipase Human genes 0.000 claims abstract description 85
- 239000004367 Lipase Substances 0.000 claims abstract description 85
- 108090001060 Lipase Proteins 0.000 claims abstract description 85
- 235000019421 lipase Nutrition 0.000 claims abstract description 85
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 55
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 39
- 238000005886 esterification reaction Methods 0.000 claims abstract description 21
- 230000032050 esterification Effects 0.000 claims abstract description 18
- 241001291477 Malassezia restricta Species 0.000 claims abstract description 17
- 241000556533 uncultured marine bacterium Species 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 12
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims description 8
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims description 8
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims description 8
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000005642 Oleic acid Substances 0.000 claims description 8
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims description 8
- 239000013612 plasmid Substances 0.000 abstract description 30
- 238000010276 construction Methods 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 11
- 238000011144 upstream manufacturing Methods 0.000 abstract description 8
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 7
- 239000000194 fatty acid Substances 0.000 abstract description 7
- 229930195729 fatty acid Natural products 0.000 abstract description 7
- 150000004665 fatty acids Chemical class 0.000 abstract description 7
- 238000001976 enzyme digestion Methods 0.000 abstract description 6
- 239000004519 grease Substances 0.000 abstract description 5
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 238000000199 molecular distillation Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 229940040461 lipase Drugs 0.000 description 79
- 102000004169 proteins and genes Human genes 0.000 description 31
- 230000014509 gene expression Effects 0.000 description 29
- 229940088598 enzyme Drugs 0.000 description 23
- 125000005456 glyceride group Chemical group 0.000 description 16
- 238000000034 method Methods 0.000 description 15
- 235000011187 glycerol Nutrition 0.000 description 13
- 238000000746 purification Methods 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000000203 mixture Substances 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 241000672609 Escherichia coli BL21 Species 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 238000004128 high performance liquid chromatography Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000012258 culturing Methods 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 238000012216 screening Methods 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 108010050848 glycylleucine Proteins 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000010775 animal oil Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000021588 free fatty acids Nutrition 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- 239000008158 vegetable oil Substances 0.000 description 3
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 101000864057 Homo sapiens Serine/threonine-protein kinase SMG1 Proteins 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- IVFUVMSKSFSFBT-NHCYSSNCSA-N Lys-Ile-Gly Chemical compound OC(=O)CNC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN IVFUVMSKSFSFBT-NHCYSSNCSA-N 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 102100029938 Serine/threonine-protein kinase SMG1 Human genes 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- 229930027917 kanamycin Natural products 0.000 description 2
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 2
- 229960000318 kanamycin Drugs 0.000 description 2
- 229930182823 kanamycin A Natural products 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- NHLAEBFGWPXFGI-WHFBIAKZSA-N Ala-Gly-Asn Chemical compound C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N NHLAEBFGWPXFGI-WHFBIAKZSA-N 0.000 description 1
- QHASENCZLDHBGX-ONGXEEELSA-N Ala-Gly-Phe Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QHASENCZLDHBGX-ONGXEEELSA-N 0.000 description 1
- NBTGEURICRTMGL-WHFBIAKZSA-N Ala-Gly-Ser Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O NBTGEURICRTMGL-WHFBIAKZSA-N 0.000 description 1
- MNZHHDPWDWQJCQ-YUMQZZPRSA-N Ala-Leu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O MNZHHDPWDWQJCQ-YUMQZZPRSA-N 0.000 description 1
- XHNLCGXYBXNRIS-BJDJZHNGSA-N Ala-Lys-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O XHNLCGXYBXNRIS-BJDJZHNGSA-N 0.000 description 1
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 1
- PEEYDECOOVQKRZ-DLOVCJGASA-N Ala-Ser-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PEEYDECOOVQKRZ-DLOVCJGASA-N 0.000 description 1
- YEBZNKPPOHFZJM-BPNCWPANSA-N Ala-Tyr-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O YEBZNKPPOHFZJM-BPNCWPANSA-N 0.000 description 1
- GIVWETPOBCRTND-DCAQKATOSA-N Arg-Gln-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GIVWETPOBCRTND-DCAQKATOSA-N 0.000 description 1
- LFAUVOXPCGJKTB-DCAQKATOSA-N Arg-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N LFAUVOXPCGJKTB-DCAQKATOSA-N 0.000 description 1
- VYZBPPBKFCHCIS-WPRPVWTQSA-N Arg-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N VYZBPPBKFCHCIS-WPRPVWTQSA-N 0.000 description 1
- QLSRIZIDQXDQHK-RCWTZXSCSA-N Arg-Val-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QLSRIZIDQXDQHK-RCWTZXSCSA-N 0.000 description 1
- JRVABKHPWDRUJF-UBHSHLNASA-N Asn-Asn-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N JRVABKHPWDRUJF-UBHSHLNASA-N 0.000 description 1
- OLGCWMNDJTWQAG-GUBZILKMSA-N Asn-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(N)=O OLGCWMNDJTWQAG-GUBZILKMSA-N 0.000 description 1
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 1
- BKZFBJYIVSBXCO-KKUMJFAQSA-N Asn-Phe-His Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O BKZFBJYIVSBXCO-KKUMJFAQSA-N 0.000 description 1
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 1
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 1
- PUUPMDXIHCOPJU-HJGDQZAQSA-N Asn-Thr-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O PUUPMDXIHCOPJU-HJGDQZAQSA-N 0.000 description 1
- OEDJQRXNDRUGEU-SRVKXCTJSA-N Asp-Leu-His Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O OEDJQRXNDRUGEU-SRVKXCTJSA-N 0.000 description 1
- DJCAHYVLMSRBFR-QXEWZRGKSA-N Asp-Met-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC(O)=O DJCAHYVLMSRBFR-QXEWZRGKSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- KNOGLZBISUBTFW-QRTARXTBSA-N Asp-Trp-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C(C)C)C(O)=O KNOGLZBISUBTFW-QRTARXTBSA-N 0.000 description 1
- FWYBFUDWUUFLDN-FXQIFTODSA-N Cys-Asp-Arg Chemical compound C(C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N FWYBFUDWUUFLDN-FXQIFTODSA-N 0.000 description 1
- MXZYQNJCBVJHSR-KATARQTJSA-N Cys-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)N)O MXZYQNJCBVJHSR-KATARQTJSA-N 0.000 description 1
- YJIUYQKQBBQYHZ-ACZMJKKPSA-N Gln-Ala-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O YJIUYQKQBBQYHZ-ACZMJKKPSA-N 0.000 description 1
- LWDGZZGWDMHBOF-FXQIFTODSA-N Gln-Glu-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O LWDGZZGWDMHBOF-FXQIFTODSA-N 0.000 description 1
- ORYMMTRPKVTGSJ-XVKPBYJWSA-N Gln-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O ORYMMTRPKVTGSJ-XVKPBYJWSA-N 0.000 description 1
- SBHVGKBYOQKAEA-SDDRHHMPSA-N Gln-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SBHVGKBYOQKAEA-SDDRHHMPSA-N 0.000 description 1
- YRWWJCDWLVXTHN-LAEOZQHASA-N Gln-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)N)N YRWWJCDWLVXTHN-LAEOZQHASA-N 0.000 description 1
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 1
- ZHNHJYYFCGUZNQ-KBIXCLLPSA-N Glu-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O ZHNHJYYFCGUZNQ-KBIXCLLPSA-N 0.000 description 1
- IDEODOAVGCMUQV-GUBZILKMSA-N Glu-Ser-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IDEODOAVGCMUQV-GUBZILKMSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- LLXVQPKEQQCISF-YUMQZZPRSA-N Gly-Asp-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN LLXVQPKEQQCISF-YUMQZZPRSA-N 0.000 description 1
- VUUOMYFPWDYETE-WDSKDSINSA-N Gly-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)CN VUUOMYFPWDYETE-WDSKDSINSA-N 0.000 description 1
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 1
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 1
- FKESCSGWBPUTPN-FOHZUACHSA-N Gly-Thr-Asn Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O FKESCSGWBPUTPN-FOHZUACHSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- IGBBXBFSLKRHJB-BZSNNMDCSA-N His-Lys-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CN=CN1 IGBBXBFSLKRHJB-BZSNNMDCSA-N 0.000 description 1
- PZAJPILZRFPYJJ-SRVKXCTJSA-N His-Ser-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O PZAJPILZRFPYJJ-SRVKXCTJSA-N 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- YNMQUIVKEFRCPH-QSFUFRPTSA-N Ile-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O)N YNMQUIVKEFRCPH-QSFUFRPTSA-N 0.000 description 1
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 1
- IALVDKNUFSTICJ-GMOBBJLQSA-N Ile-Met-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N IALVDKNUFSTICJ-GMOBBJLQSA-N 0.000 description 1
- WCNWGAUZWWSYDG-SVSWQMSJSA-N Ile-Thr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)O)N WCNWGAUZWWSYDG-SVSWQMSJSA-N 0.000 description 1
- 108010093096 Immobilized Enzymes Proteins 0.000 description 1
- 229910002570 KH2PO4-Na2HPO4 Inorganic materials 0.000 description 1
- YWKNKRAKOCLOLH-OEAJRASXSA-N Leu-Phe-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YWKNKRAKOCLOLH-OEAJRASXSA-N 0.000 description 1
- MUCIDQMDOYQYBR-IHRRRGAJSA-N Leu-Pro-His Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N MUCIDQMDOYQYBR-IHRRRGAJSA-N 0.000 description 1
- JDBQSGMJBMPNFT-AVGNSLFASA-N Leu-Pro-Val Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(O)=O JDBQSGMJBMPNFT-AVGNSLFASA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- YLMIDMSLKLRNHX-HSCHXYMDSA-N Leu-Trp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YLMIDMSLKLRNHX-HSCHXYMDSA-N 0.000 description 1
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 1
- 102000017055 Lipoprotein Lipase Human genes 0.000 description 1
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 1
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 1
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 1
- WINFHLHJTRGLCV-BZSNNMDCSA-N Lys-Tyr-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=C(O)C=C1 WINFHLHJTRGLCV-BZSNNMDCSA-N 0.000 description 1
- WXJXYMFUTRXRGO-UWVGGRQHSA-N Met-His-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CNC=N1 WXJXYMFUTRXRGO-UWVGGRQHSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108050006759 Pancreatic lipases Proteins 0.000 description 1
- 102000019280 Pancreatic lipases Human genes 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 244000271379 Penicillium camembertii Species 0.000 description 1
- 235000002245 Penicillium camembertii Nutrition 0.000 description 1
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 1
- UNLYPPYNDXHGDG-IHRRRGAJSA-N Phe-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UNLYPPYNDXHGDG-IHRRRGAJSA-N 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- FYQSMXKJYTZYRP-DCAQKATOSA-N Pro-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 FYQSMXKJYTZYRP-DCAQKATOSA-N 0.000 description 1
- OOLOTUZJUBOMAX-GUBZILKMSA-N Pro-Ala-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O OOLOTUZJUBOMAX-GUBZILKMSA-N 0.000 description 1
- NHDVNAKDACFHPX-GUBZILKMSA-N Pro-Arg-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O NHDVNAKDACFHPX-GUBZILKMSA-N 0.000 description 1
- OYEUSRAZOGIDBY-JYJNAYRXSA-N Pro-Arg-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OYEUSRAZOGIDBY-JYJNAYRXSA-N 0.000 description 1
- VOHFZDSRPZLXLH-IHRRRGAJSA-N Pro-Asn-Phe Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VOHFZDSRPZLXLH-IHRRRGAJSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 1
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 1
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 1
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 1
- VLMIUSLQONKLDV-HEIBUPTGSA-N Ser-Thr-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VLMIUSLQONKLDV-HEIBUPTGSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 241000223258 Thermomyces lanuginosus Species 0.000 description 1
- JNQZPAWOPBZGIX-RCWTZXSCSA-N Thr-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)CCCN=C(N)N JNQZPAWOPBZGIX-RCWTZXSCSA-N 0.000 description 1
- QNJYPWZACBACER-KKUMJFAQSA-N Tyr-Asp-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O QNJYPWZACBACER-KKUMJFAQSA-N 0.000 description 1
- JHORGUYURUBVOM-KKUMJFAQSA-N Tyr-His-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O JHORGUYURUBVOM-KKUMJFAQSA-N 0.000 description 1
- WDGDKHLSDIOXQC-ACRUOGEOSA-N Tyr-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 WDGDKHLSDIOXQC-ACRUOGEOSA-N 0.000 description 1
- ZMKDQRJLMRZHRI-ACRUOGEOSA-N Tyr-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N ZMKDQRJLMRZHRI-ACRUOGEOSA-N 0.000 description 1
- QPOUERMDWKKZEG-HJPIBITLSA-N Tyr-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 QPOUERMDWKKZEG-HJPIBITLSA-N 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- NXRAUQGGHPCJIB-RCOVLWMOSA-N Val-Gly-Asn Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O NXRAUQGGHPCJIB-RCOVLWMOSA-N 0.000 description 1
- PTFPUAXGIKTVNN-ONGXEEELSA-N Val-His-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)NCC(=O)O)N PTFPUAXGIKTVNN-ONGXEEELSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- DEGUERSKQBRZMZ-FXQIFTODSA-N Val-Ser-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DEGUERSKQBRZMZ-FXQIFTODSA-N 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012148 binding buffer Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 108010060199 cysteinylproline Proteins 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- -1 diglycerides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 1
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 1
- 108010028188 glycyl-histidyl-serine Proteins 0.000 description 1
- 108010089804 glycyl-threonine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 108010053037 kyotorphin Proteins 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 108010045397 lysyl-tyrosyl-lysine Proteins 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229940116369 pancreatic lipase Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 108010084572 phenylalanyl-valine Proteins 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 108010004914 prolylarginine Proteins 0.000 description 1
- 239000012474 protein marker Substances 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 108010031491 threonyl-lysyl-glutamic acid Proteins 0.000 description 1
- 108010071097 threonyl-lysyl-proline Proteins 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 108010015385 valyl-prolyl-proline Proteins 0.000 description 1
- 108010009962 valyltyrosine Proteins 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000012130 whole-cell lysate Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
- C12P7/6436—Fatty acid esters
- C12P7/6445—Glycerides
- C12P7/6454—Glycerides by esterification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
The invention belongs to the fields of food biotechnology and oil processing and comprehensive utilization, and particularly relates to an enzyme for synthesizing diglyceride, a preparation method and application thereof; s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained. The marine bacterium Malassezia restricta lipase MRL prepared by the invention has good esterification activity, can efficiently catalyze glycerol and fatty acid to form monoglyceride and diglyceride, and the content of the diglyceride in the product reaches 30% -50%. The high-purity grease obtained by molecular distillation of the product contains 80-93% of diglyceride, and has obvious industrial production potential.
Description
Technical Field
The invention belongs to the fields of food biotechnology and oil processing and comprehensive utilization, and in particular relates to an enzyme for synthesizing diglyceride, a preparation method and application thereof.
Background
Diglyceride (DAG) is a structural lipid formed by esterifying two hydroxyl groups in glycerol with fatty acid, mainly comprising two isomers of 1,2-DAG and 1,3-DAG, and is a well-recognized safety (GRAS) food ingredient. The metabolic pathway of diglyceride is different from that of triglyceride, and after being taken by human body, it is decomposed by pancreatic lipase to produce glycerin and free fatty acid, and can be directly converted into energy, and does not participate in blood lipid synthesis, so that it can not raise blood lipid, and can not cause obesity. Therefore, the diglyceride can be used as a health care grease and a medical intermediate, and has very important application value in the industries of food, medicine and chemical industry.
Diglycerides are products with different DAG contents, which are prepared by taking animal and vegetable oil, glycerol and fatty acid as raw materials through hydrolysis, esterification, transesterification, acidolysis, alcoholysis and other reactions. In general, there are three methods for preparing diglycerides: hydrolysis, glycerolysis and esterification. The hydrolysis method is to moderately hydrolyze refined animal and vegetable oil with sn-1, 3-site specific lipase to obtain diglyceride, and the DAG content of the oil prepared by the method is usually not more than 60% after molecular distillation purification. The glycerolysis method adopts free enzyme or immobilized enzyme, uses refined animal and vegetable oil and glycerin as substrates, and carries out glycerolysis reaction under a solvent or solvent-free system, wherein the DAG content in the oil prepared by the method is generally 50-85%, but the reaction is greatly restricted by the type of enzyme preparation, the solvent, the lipase position selectivity and other conditions. The esterification method is to esterify glycerin and fatty acid by using lipase or partial glyceride lipase with sn-1, 3-position specificity to obtain the DAG-rich grease, the DAG content of the prepared DAG is up to more than 90%, especially the DAG content of the grease prepared by esterification of partial glyceride lipase can be up to more than 97%. Therefore, the esterification method for producing high-purity diglycerides has great advantages.
At present, the partial glyceride lipase for producing high-purity diglyceride has few sources, the commercial partial glyceride lipase with sn-1, 3-position specificity is respectively from thermophilic fungi Thermomyces lanuginosus and penicillium Penicillium camemberti, and is a powdery free enzyme preparation obtained by fermentation production, purification and drying, and the cost is high. The only partial glyceride lipases reported in the literature include lipases SMG1, mgDL2 and PCL, but none of them is used for commercial production of diglycerides.
Therefore, the invention provides an enzyme for synthesizing high-purity diglyceride, and a preparation method and application thereof.
Disclosure of Invention
The invention aims at solving the defect of the prior art for preparing diglyceride lipase resources in China, providing an enzyme for synthesizing high-purity diglyceride, a preparation method and application thereof, determining the optimal condition for synthesizing diglyceride, and enriching the lipase resources for producing diglyceride by an esterification method in China.
In order to achieve the above purpose, the present invention adopts the following technical scheme.
A preparation method of an enzyme for synthesizing high-purity diglyceride comprises the following steps:
s1: by synthesizing the gene of marine bacterium Malassezia restricta lipase MRL;
s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained.
S3: construction of lipase MRL protein expression strains: the recombinant plasmid pET30a-MRL is introduced into escherichia coli BL21, and positive transformants are obtained through screening, namely the lipase MRL protein expression strain.
S4: lipase MRL protein expression and purification: culturing lipase MRL protein expression strain, inducing protein expression, purifying and drying to obtain lipase MRL dry powder.
Preferably, when the molar ratio of oleic acid to glycerol is 1:1-1:5, the enzyme addition amount is 2% -10% of the total mass of the substrate, the reaction temperature is 25 ℃ -50 ℃, the content of diglyceride in the obtained oil after 2-20 h reaction is 30% -50%, and the esterification rate can reach 60% -85%.
The invention has the following beneficial effects:
the partial glyceride lipase MRL from marine bacteria Malassezia restricta prepared by the invention has good esterification activity, can efficiently catalyze glycerin and fatty acid to form monoglyceride and diglyceride, the esterification rate reaches 60% -85%, the diglyceride content in the product reaches 30% -50%, and the high-purity grease obtained by molecular distillation of the product contains 80-93% of diglyceride, so that the partial glyceride lipase MRL has obvious industrial production potential.
Drawings
FIG. 1 is a schematic diagram of construction of lipase MRL gene expression plasmid.
FIG. 2 is an electrophoresis diagram of the purification of the MRL protein of the lipase.
FIG. 3 shows the effect of the addition of lipase MRL on the esterification rate and glyceride content.
In the figure: m is a protein Marker; 1. is whole cell lysate; 2. is supernatant protein; 3. is a cell debris; 4. the protein purified by the Ni column; 5. is desalted protein.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments.
A preparation method of an enzyme for synthesizing high-purity diglyceride comprises the following steps:
s1: by synthesizing the gene of marine bacterium Malassezia restricta lipase MRL;
s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained.
S3: construction of lipase MRL protein expression strains: the recombinant plasmid pET30a-MRL is introduced into escherichia coli BL21, and positive transformants are obtained through screening, namely the lipase MRL protein expression strain.
S4: lipase MRL protein expression and purification: culturing lipase MRL protein expression strain, inducing protein expression, purifying and drying to obtain lipase MRL dry powder.
(1) Strains, enzymes and culture media
Chemically competent cells of E.coli Escherichia coli Top and E.coli Escherichia coli BL; DNA polymerase (Ex Taq DNA polymerase) was purchased from Dalian Takara, DNA ligase (T4 DNA ligase) and restriction endonucleases NdeI and HindIII were purchased from Thermo Fisher Scientific; the LB medium comprises the following components of Tryptone 10 g/L, yeast extract 5 g/L and NaCl 10 g/L; kanamycin concentration was 50 ug/mL; expression vector pET30a was stored for this laboratory.
(2) Gene synthesis, PCR amplification and recombinant plasmid construction of lipase MRL
In this example, blast alignment analysis was performed in NCBI database based on the disclosed amino acid sequence of partial glyceride lipase SMG1 (Genbank ID: EDP 44990.1), and gene synthesis was performed to obtain the gene sequence (SEQ ID NO. 1) of marine bacterium Malassezia restricta lipase MRL having extremely high sequence homology with it.
The gene sequence of the synthesized lipase MRL is used as a template, and the gene of the lipase MRL is amplified by PCR by using an upstream primer F (the sequence is shown as SEQ ID NO. 3) and a downstream primer R (the sequence is shown as SEQ ID NO. 4). The system of PCR reaction (50) uL was as follows: template 1 uL (50 ng), dNTP mix 1 uL, primers (10 uM/L) each 1 uL,10 XPCR buffer 5 uL, DNA polymerase (5U/L) 0.2 uL, and sterile water to 50 uL. The PCR amplification conditions were as follows: 94. 3 min at 94 ℃, 30 s at 56 ℃, 30 s at 72 ℃ for 1 min,31 cycles. The PCR amplified product was recovered by agarose electrophoresis, digested with restriction enzymes NdeI and HindIII, ligated with plasmid pET30a digested with NdeI and HindIII, transformed into E.coli Top10, and positive transformants were selected, cultured overnight at 37℃and 200rpm, and plasmids were extracted to obtain recombinant plasmid pET30a-MRL (plasmid map see FIG. 1).
(3) Construction, induced expression and purification of lipase MRL gene expression strain
And (3) introducing the recombinant plasmid pET30a-MRL into the chemocompetence of the escherichia coli BL21 by adopting a heat shock method, and obtaining a positive transformant by colony PCR verification, namely the lipase MRL protein expression strain. E.coli BL21 introduced with recombinant plasmid pET30a-MRL is inoculated into LB culture medium containing 50 ug/mL kanamycin, cultured at 37 ℃ and 200rpm until the OD value reaches 0.6-0.8, added with IPTG with the final concentration of 0.5 mM to induce 16 h at 15 ℃, centrifugally collected thalli, added with lysate (20 mM Tris-HCl, 500 mM NaCl, 5% glycol and pH 8.0) to carry out ultrasonic disruption, centrifuged at 4 ℃ and 15000 rpm for 20 min, and the supernatant is taken out, and then separated and purified by a Ni-NTA purification resin pre-packed column of 5 mL.
The Binding buffer solution required by Ni-NTA purification resin pre-packed column separation and purification of lipase MRL comprises the following components: 20 mM Tris-HCl, 500 mM NaCl, 10 mM imidazole, pH 8.0; the composition of the solution buffer is as follows: 20 M Tris-HCl, 500 mM NaCl, 250 mM imidazole, pH 8.0; the elution rate was 1 mL/min. The protein samples obtained by column chromatography were subjected to SDS-PAGE gel electrophoresis to examine the purification effect (as shown in FIG. 2). And desalting and freeze-drying the purified sample to obtain lipase MRL dry powder.
Example 2
A method for preparing an enzyme for synthesizing high-purity diglyceride, which is characterized by comprising the following steps:
s1: by synthesizing the gene of marine bacterium Malassezia restricta lipase MRL;
s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained.
S3: construction of lipase MRL protein expression strains: the recombinant plasmid pET30a-MRL is introduced into escherichia coli BL21, and positive transformants are obtained through screening, namely the lipase MRL protein expression strain.
S4: lipase MRL protein expression and purification: culturing lipase MRL protein expression strain, inducing protein expression, purifying and drying to obtain lipase MRL dry powder.
Analysis of Effect of Lipase MRL on hydrolysis of different glyceride substrates
10 g camellia oil (triglyceride content 98%), diglycerides (1, 2-and 1, 3-dioleate, available from Avanti) and monoglyceride were added to 3 50 mL triangular flasks, respectively, and 5 g water was added thereto, followed by preheating in a shaker at 30℃for 20 min, and then adding 100U/g (U/w, mass of oil) of lipase MRL, for reaction. Samples were taken at intervals of 150 uL, centrifuged at 12000 rpm for 2 min, the upper oil phase was taken in a 1.5 mLEP tube and the glyceride composition of the samples was checked by HPLC. The mobile phase of HPLC was: n-hexane/isopropanol/formic acid (15:1:0.003, v/v/v), filtration with a 0.45. 0.45 uM filter membrane, and degassing by sonication for 30 min; the column was a silica column (250 mm X4.6 mm, particle size 5 μm). 20 uL oil sample was taken and mixed with 1 mL mobile phase, dehydrated with anhydrous sodium sulfate and transferred to a sample bottle. The content of triglycerides, diglycerides, monoglycerides and free fatty acids in the samples was determined by HPLC. As a result, it was found that lipase MRL was not capable of hydrolyzing camellia oil (triglyceride content 98%), was capable of hydrolyzing diglycerides (1, 3-DAG,1, 2-DAG) and monoglycerides, and it was confirmed that lipase MRL was a monoester and diester lipase, belonging to the partial glyceride lipase.
Example 3
A method for preparing an enzyme for synthesizing high-purity diglyceride, which is characterized by comprising the following steps:
s1: genes for lipase MRL by marine bacteria Malassezia restricta;
s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained.
S3: construction of lipase MRL protein expression strains: the recombinant plasmid pET30a-MRL is introduced into escherichia coli BL21, and positive transformants are obtained through screening, namely the lipase MRL protein expression strain.
S4: lipase MRL protein expression and purification: culturing lipase MRL protein expression strain, inducing protein expression, purifying and drying to obtain lipase MRL dry powder.
Hydrolysis Activity determination of Lipase MRL
The activity of lipase MRL was determined by diglyceride emulsification: first, 4% of polyvinyl alcohol AH-26 was mixed with diglyceride (1, 3-dioleate, available from Avanti) at a mass ratio of 3:1, and homogeneously emulsified with a homogenizer at 10 000 rpm for 10 min until the emulsion became milky white and free of oil droplets. Then, adding diglyceride emulsion 4 mL and 5 mL of KH2PO4-Na2HPO4 buffer of 0.05 mol/L with pH 5.6 into a triangular flask, preheating for 5 min in a constant temperature magnetic stirrer at 30 ℃, accurately adding enzyme solution 100 uL and starting timing, and immediately adding 95% ethanol 15 mL after 30 min of reaction to terminate the reaction. Finally, the reaction flask is taken out, 1 drop of phenolphthalein indicator is added, the calibrated KOH solution with the concentration of about 0.05 mol/L is used for titrating free fatty acid released by the hydrolysis of the lipase MRL, and the volume consumed by KOH is accurately recorded. The blank test is to add 95% ethanol into the preheated reaction system, then add the enzyme solution 100 uL (the enzyme solution is heated for 15 min at 100 ℃ and used after being cooled to room temperature) after heat inactivation treatment, and then react for 30 min, and the other operations are the same as before. 1 enzyme activity unit (U): under the above assay conditions (i.e., specific temperature and reaction conditions), the amount of enzyme required to hydrolyze the diglyceride per minute to produce 1 umol of titratable fatty acid. The lipase MRL has a hydrolase activity of 4800U/g as measured by the above method using diglyceride as a substrate.
Example 4
A method for preparing an enzyme for synthesizing high-purity diglyceride, which is characterized by comprising the following steps:
s1: genes for lipase MRL by marine bacteria Malassezia restricta;
s2: construction of recombinant plasmids: the gene sequence of Malassezia restricta lipase MRL obtained in the step S1 is used as a template, the lipase MRL gene is amplified by using an upstream primer F and a downstream primer R, and is connected with a plasmid pET30a after double enzyme digestion, so that a recombinant plasmid pET30a-MRL is obtained.
S3: construction of lipase MRL protein expression strains: the recombinant plasmid pET30a-MRL is introduced into escherichia coli BL21, and positive transformants are obtained through screening, namely the lipase MRL protein expression strain.
S4: lipase MRL protein expression and purification: culturing lipase MRL protein expression strain, inducing protein expression, purifying and drying to obtain lipase MRL dry powder.
The oleic acid and the glycerol are used as substrates, the influence of enzyme addition amount, reaction substrate molar ratio and reaction temperature on the synthesis of diglyceride by the esterification of the glycerol and the fatty acid by the lipase MRL is researched through a single factor experiment, and the optimal reaction condition for synthesizing the oleic acid diglyceride is determined.
(1) Influence of the enzyme addition amount on the esterification reaction
Mixing oleic acid and glycerin according to a molar ratio of 1:4, adding into a triangular flask, setting the addition amount of lipase MRL to be 2, 4, 6, 8 and 10% of the total mass of a substrate, and placing the triangular flask at 30 ℃ for stirring reaction. The upper layer oil was sampled at timing (2, 4, 6, 8, 10, 20, h), the glyceride composition of the mixture was analyzed by the HPLC method in example 2, and the esterification rate was calculated. The effect of the amount of lipase MRL addition on the esterification rate and glyceride content is shown in FIG. 3.
(2) Effect of reaction substrate molar ratio on esterification reaction
Mixing oleic acid and glycerol according to a certain molar ratio (1:1, 1:2, 1:3, 1:4 and 1:5), adding into a triangular flask, wherein the addition amount of lipase MRL is 6% of the total mass of a substrate, and placing the triangular flask at 30 ℃ for stirring reaction. The upper layer oil was sampled at timing (2, 4, 6, 8, 10, 20, h), the glyceride composition of the mixture was analyzed by the HPLC method in example 2, and the esterification rate was calculated.
(3) Influence of the reaction temperature on the esterification reaction
Mixing oleic acid and glycerol according to a molar ratio of 1:4, adding into a triangular flask, wherein the addition amount of lipase MRL is 6% of the total mass of the substrate, and respectively placing the triangular flask at 25 ℃, 30 ℃, 35 ℃, 40 ℃ and 50 ℃ for stirring reaction. The upper layer oil was sampled at timing (2, 4, 6, 8, 10, 20, h), the glyceride composition of the mixture was analyzed by the HPLC method in example 2, and the esterification rate was calculated.
The result shows that when the molar ratio of oleic acid to glycerin is 1:4, the enzyme addition amount is 6% of the total mass of the substrate, the reaction temperature is 30 ℃, the reaction is 20. 20h, the content of diglyceride is 49.61%, and the esterification rate can reach 84.31%.
SEQ ID NO. 1: gene sequence of marine bacterium Malassezia restricta lipase MRL
ATGCTCTTCAATCGTATTGCTCTGTTTGCTGCAAGCTGCGCGGCTCTTGTATCTGCCGGTCCATTGAACTTTCATGCCGGTAGTTCGAAGGATCAGCCAGTCTCCAACAACTGGAACACTAAGGAAATCTCGCAGGCCGCAGGTCTTGTTCAACAGACCTACTGTGACCGTTCCACTACTAAGCCTGGTCTGAAGATCGGAGATTCTACTCTTCTTTTCACTGCTGGTAATGGTGATCATCGCCAGCGCTTCAATCTGTACCACTCGGAGAGCCTTGGAATTGCCGTGGCCATTGAAGGTACAAACCTGACCTCGATTACGTCTGATCTCCATGATGTCAAGGGTCTACCTGTCTTGCCTCATCCGCGCTACCGCTCGCATTATCCTGAGGGCACAAGGGTGATGCATGGCTTCCAGGAGGCCTACGTCAGTATCATGGACGATATGGTACGCGCTATCGAAAAGTACAAGAAGGAAAAGAATGAGAAACGAGTCACCATAATTGGTCACTCGCTGGGTGCTGCTATGGGTTTGCTTGCTGCTATGGATGTTGAACTTCGCCTGGATGACGGTATTTGCAAGACTTATCTATTTGGTCTGCCCCGCGTCGGTAACCCAACCTTTGCTGGATTCGTTGACGAAAAGATCGGTCATAAGTTTTACTCAATCATCAATGGTCAAGACTGGGTCCCCGCCGTCCCTCCTCGTGCCCTTGGTTATCAGCACCCATCGAACTACTTGTGGATTTACCCAGGTAACTCGACTAATGCTAAGATCTATCCCGGCCAGGAAAACGTCCACGGTATTCTTACTGTGCCCCGCGCCCCTAACTTCTACGACCACCAGGGCGTGTACTTCCACACTCAAATCGGTGCTTCCTTCGGTCAGTGCCCTGCCAAGGTTGGCAACATGTAA
SEQ ID NO. 2: amino acid sequence of marine bacterium Malassezia restricta lipase MRL
MLFNRIALFAASCAALVSAGPLNFHAGSSKDQPVSNNWNTKEISQAAGLVQQTYCDRSTTKPGLKIGDSTLLFTAGNGDHRQRFNLYHSESLGIAVAIEGTNLTSITSDLHDVKGLPVLPHPRYRSHYPEGTRVMHGFQEAYVSIMDDMVRAIEKYKKEKNEKRVTIIGHSLGAAMGLLAAMDVELRLDDGICKTYLFGLPRVGNPTFAGFVDEKIGHKFYSIINGQDWVPAVPPRALGYQHPSNYLWIYPGNSTNAKIYPGQENVHGILTVPRAPNFYDHQGVYFHTQIGASFGQCPAKVGNM
SEQ ID NO. 3: upstream primer F sequence
CCATATGATGCTCTTCAATCGTATTGCTC
SEQ ID NO. 4: downstream primer F sequence
CAAGCTTCATGTTGCCAACCTTGGC
The foregoing is only a preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art, who is within the scope of the present invention, should make equivalent substitutions or modifications according to the technical scheme of the present invention and the inventive concept thereof, and should be covered by the scope of the present invention.
<110> Jiangsu Hefeng grain and oil industry Co., ltd., jiangsu university
<120> an enzyme for synthesizing high purity diglyceride, its preparation method and application
<160> 2
<170> PatentIn version 3.5
<210> 1
<211> 915
<212> DNA
<213> unknown
<400> 1
atgctcttca atcgtattgc tctgtttgct gcaagctgcg cggctcttgt atctgccggt 60
ccattgaact ttcatgccgg tagttcgaag gatcagccag tctccaacaa ctggaacact 120
aaggaaatct cgcaggccgc aggtcttgtt caacagacct actgtgaccg ttccactact 180
aagcctggtc tgaagatcgg agattctact cttcttttca ctgctggtaa tggtgatcat 240
cgccagcgct tcaatctgta ccactcggag agccttggaa ttgccgtggc cattgaaggt 300
acaaacctga cctcgattac gtctgatctc catgatgtca agggtctacc tgtcttgcct 360
catccgcgct accgctcgca ttatcctgag ggcacaaggg tgatgcatgg cttccaggag 420
gcctacgtca gtatcatgga cgatatggta cgcgctatcg aaaagtacaa gaaggaaaag 480
aatgagaaac gagtcaccat aattggtcac tcgctgggtg ctgctatggg tttgcttgct 540
gctatggatg ttgaacttcg cctggatgac ggtatttgca agacttatct atttggtctg 600
ccccgcgtcg gtaacccaac ctttgctgga ttcgttgacg aaaagatcgg tcataagttt 660
tactcaatca tcaatggtca agactgggtc cccgccgtcc ctcctcgtgc ccttggttat 720
cagcacccat cgaactactt gtggatttac ccaggtaact cgactaatgc taagatctat 780
cccggccagg aaaacgtcca cggtattctt actgtgcccc gcgcccctaa cttctacgac 840
caccagggcg tgtacttcca cactcaaatc ggtgcttcct tcggtcagtg ccctgccaag 900
gttggcaaca tgtaa 915
<210> 2
<211> 304
<212> PRT
<213> unknown
<400> 2
Met Leu Phe Asn Arg Ile Ala Leu Phe Ala Ala Ser Cys Ala Ala Leu
1 5 10 15
Val Ser Ala Gly Pro Leu Asn Phe His Ala Gly Ser Ser Lys Asp Gln
20 25 30
Pro Val Ser Asn Asn Trp Asn Thr Lys Glu Ile Ser Gln Ala Ala Gly
35 40 45
Leu Val Gln Gln Thr Tyr Cys Asp Arg Ser Thr Thr Lys Pro Gly Leu
50 55 60
Lys Ile Gly Asp Ser Thr Leu Leu Phe Thr Ala Gly Asn Gly Asp His
65 70 75 80
Arg Gln Arg Phe Asn Leu Tyr His Ser Glu Ser Leu Gly Ile Ala Val
85 90 95
Ala Ile Glu Gly Thr Asn Leu Thr Ser Ile Thr Ser Asp Leu His Asp
100 105 110
Val Lys Gly Leu Pro Val Leu Pro His Pro Arg Tyr Arg Ser His Tyr
115 120 125
Pro Glu Gly Thr Arg Val Met His Gly Phe Gln Glu Ala Tyr Val Ser
130 135 140
Ile Met Asp Asp Met Val Arg Ala Ile Glu Lys Tyr Lys Lys Glu Lys
145 150 155 160
Asn Glu Lys Arg Val Thr Ile Ile Gly His Ser Leu Gly Ala Ala Met
165 170 175
Gly Leu Leu Ala Ala Met Asp Val Glu Leu Arg Leu Asp Asp Gly Ile
180 185 190
Cys Lys Thr Tyr Leu Phe Gly Leu Pro Arg Val Gly Asn Pro Thr Phe
195 200 205
Ala Gly Phe Val Asp Glu Lys Ile Gly His Lys Phe Tyr Ser Ile Ile
210 215 220
Asn Gly Gln Asp Trp Val Pro Ala Val Pro Pro Arg Ala Leu Gly Tyr
225 230 235 240
Gln His Pro Ser Asn Tyr Leu Trp Ile Tyr Pro Gly Asn Ser Thr Asn
245 250 255
Ala Lys Ile Tyr Pro Gly Gln Glu Asn Val His Gly Ile Leu Thr Val
260 265 270
Pro Arg Ala Pro Asn Phe Tyr Asp His Gln Gly Val Tyr Phe His Thr
275 280 285
Gln Ile Gly Ala Ser Phe Gly Gln Cys Pro Ala Lys Val Gly Asn Met
290 295 300
<210> 3
<211> 29
<212> DNA
<213> unknown
<400> 3
ccatatgatg ctcttcaatc gtattgctc 29
<210> 4
<211> 25
<212> DNA
<213> unknown
<400> 4
caagcttcat gttgccaacc ttggc 25
Claims (1)
1. The application of the enzyme for synthesizing the high-purity diglyceride is characterized in that when the molar ratio of oleic acid to glycerol is 1:4, marine bacterium Malassezia restricta lipase MRL with a gene sequence shown as SEQ ID NO.1 is added as 6% of the total mass of the substrate, the reaction temperature is 30 ℃, the content of the diglyceride in the oil obtained after 20h of reaction is 49.61%, and the esterification rate can reach 84.31%.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011504714.8A CN114645034B (en) | 2020-12-18 | 2020-12-18 | Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011504714.8A CN114645034B (en) | 2020-12-18 | 2020-12-18 | Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114645034A CN114645034A (en) | 2022-06-21 |
CN114645034B true CN114645034B (en) | 2024-02-09 |
Family
ID=81989860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011504714.8A Active CN114645034B (en) | 2020-12-18 | 2020-12-18 | Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114645034B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102676592A (en) * | 2012-02-29 | 2012-09-19 | 华南理工大学 | Application of lipase SMG1 in preparation of fatty acid monoglyceride |
CN103525784A (en) * | 2013-09-30 | 2014-01-22 | 华南理工大学 | Partial glyceride lipase mutant, plasmids, recombination strains, preparation methods and applications |
CN103966187A (en) * | 2014-04-30 | 2014-08-06 | 华南理工大学 | Low-temperature partial glyceride lipase of marine microorganism source and application thereof |
CN110777170A (en) * | 2019-11-06 | 2020-02-11 | 华南理工大学 | Method for synthesizing diglyceride |
CN110951796A (en) * | 2019-12-31 | 2020-04-03 | 华南理工大学 | Method for converting fatty acid ethyl ester into diglyceride |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120276247A1 (en) * | 2011-04-29 | 2012-11-01 | Uwe Bornscheuer | Lipase Variants |
-
2020
- 2020-12-18 CN CN202011504714.8A patent/CN114645034B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102676592A (en) * | 2012-02-29 | 2012-09-19 | 华南理工大学 | Application of lipase SMG1 in preparation of fatty acid monoglyceride |
CN103525784A (en) * | 2013-09-30 | 2014-01-22 | 华南理工大学 | Partial glyceride lipase mutant, plasmids, recombination strains, preparation methods and applications |
CN103966187A (en) * | 2014-04-30 | 2014-08-06 | 华南理工大学 | Low-temperature partial glyceride lipase of marine microorganism source and application thereof |
CN110777170A (en) * | 2019-11-06 | 2020-02-11 | 华南理工大学 | Method for synthesizing diglyceride |
CN110951796A (en) * | 2019-12-31 | 2020-04-03 | 华南理工大学 | Method for converting fatty acid ethyl ester into diglyceride |
Non-Patent Citations (5)
Title |
---|
Isolation and Expression of a Malassezia globosa Lipase Gene, LIP1;Yvonne M.DeAngelis;Journal of Investigative Dermatology;2138-2146 * |
lipase [Malassezia restricta] Accession.No.XP_027482916.1;PARK.M;Genbank Database;第1-2页 * |
卷枝毛霉脂肪酶及其调控脂质代谢的机制;昝新艺;中国博士学位论文全文数据库(电子期刊)工程科技Ⅰ辑;B018-15 * |
基于序列结构分析的新型甘油二酯脂肪酶挖掘策略研究;SHAHID ALI;中国博士学位论文全文数据库(电子期刊)工程科技Ⅰ辑;B016-33 * |
马拉色菌脂肪酶SMG1酶学性质表征及晶体学研究;刘璐;中国博士学位论文全文数据库(电子期刊)工程科技Ⅰ辑;B014-67 * |
Also Published As
Publication number | Publication date |
---|---|
CN114645034A (en) | 2022-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Aloulou et al. | Purification and biochemical characterization of the LIP2 lipase from Yarrowia lipolytica | |
Yu et al. | High-level expression of extracellular lipase Lip2 from Yarrowia lipolytica in Pichia pastoris and its purification and characterization | |
US11603545B2 (en) | Recombinant yeast strain for producing nervonic acids and application thereof | |
CN108642026B (en) | Partial glyceride lipase mutant and application thereof | |
CN103627685B (en) | Higher-activity partial glyceride lipase mutant and application thereof | |
Lee et al. | Multiple mutagenesis of non-universal serine codons of the Candida rugosa LIP2 gene and biochemical characterization of purified recombinant LIP2 lipase overexpressed in Pichia pastoris | |
Tecelão et al. | Production of human milk fat substitutes by interesterification of tripalmitin with ethyl oleate catalyzed by Candida parapsilosis lipase/acyltransferase | |
CN108642025B (en) | Lipase mutant with improved enzyme activity and position selectivity and application thereof | |
Ávila-Cisneros et al. | Production of thermostable lipase by Thermomyces lanuginosus on solid-state fermentation: selective hydrolysis of sardine oil | |
CN111218437B (en) | High-yield alkaline lipase, gene, strain and application | |
Bornscheuer et al. | A comparison of different strategies for lipase-catalyzed synthesis of partial glycerides | |
CN114645034B (en) | Enzyme for synthesizing high-purity diglyceride, and preparation method and application thereof | |
CN106754818B (en) | Heat-resistant esterase mutant and preparation method and application thereof | |
Roustan et al. | A novel lipase/acyltransferase from the yeast Candida albicans: expression and characterisation of the recombinant enzyme | |
Shen et al. | Improvement of amorpha-4, 11-diene production by a yeast-conform variant of Vitreoscilla hemoglobin | |
CN103805617B (en) | 1,3- specific lipases, its coding gene sequence and application thereof | |
Lee et al. | Engineering the substrate-binding domain of an esterase enhances its hydrolytic activity toward fatty acid esters | |
Yang et al. | Possible charged residue switch for acylglycerol selectivity of lipase MAS1 | |
Nietz et al. | A new lipase (Alip2) with high potential for enzymatic hydrolysis of the diester diethyladipate to the monoester monoethyladipate | |
Cho et al. | Effect of PelB signal sequences on Pfe1 expression and ω-hydroxyundec-9-enoic acid biotransformation in recombinant Escherichia coli | |
Lock et al. | Lipases produced by yeasts: powerful biocatalysts for industrial purposes | |
CN112135903A (en) | Mutant lipase and use thereof | |
Xu et al. | Surface-displayed thermostable Candida rugosa lipase 1 for docosahexaenoic acid enrichment | |
CN110982804B (en) | Lipase and application thereof in obtaining DHA (docosahexaenoic acid) glyceride enrichment | |
Cai et al. | Substitution and mutation of the C-terminal loop domain of Penicillium expansum lipase significantly changed its regioselectivity and activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |